Dynavax Technologies
DVAX
#4890
Rank
C$2.46 B
Marketcap
C$21.03
Share price
38.19%
Change (1 day)
14.06%
Change (1 year)

P/E ratio for Dynavax Technologies (DVAX)

P/E ratio as of December 2025 (TTM): -48.1

According to Dynavax Technologies 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -48.0625. At the end of 2024 the company had a P/E ratio of 60.8.

P/E ratio history for Dynavax Technologies from 2004 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202460.8
20224.61-80.03%
202123.1-504.3%
2020-5.71120.43%
2019-2.59-27.87%
2018-3.59-64.69%
2017-10.2648.72%
2016-1.36-81.52%
2015-7.3450.27%
2014-4.89
2012-6.95

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Agenus
AGEN
-1.08-97.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
16.0-133.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
14.0-129.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
19.3-140.10%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
30.5-163.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
13.6-128.33%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
14.6-130.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
50.4-204.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
25.6-153.33%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.